TLPHTalphera, Inc.

$18M

Q2 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$2M

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.15

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$223,000

Balance Sheet

Total Assets

$25M

Total Liabilities

$12M

Stockholders' Equity

$13M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$253,000	-100.0%
Gross Profit	-$2M	-$1M	-47.0%
Operating Income	-$4M	-$4M	-7.6%
Net Income	-$4M	-$4M	+12.4%

TLPH Q2 2024 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena